Company / EPS (Diluted)
Apyx Medical Corp EPS (Diluted) History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.67
FY2023
5-year range
-$0.67 / -$0.35
FY2019-FY2023
Trend
-52.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has fluctuated over the past 8 years, ranging from $-1.03 in FY2016 to $0.24 in FY2017.
Based on SEC 10-K filings.
-0.67 in FY2023.
Declined from $-0.35 to $-0.67 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, eps (diluted) decreased 52.3% year-over-year.
- Peak eps (diluted) was recorded in FY2017.
- Lowest eps (diluted) in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -$0.67 | -52.3% |
| FY2022 | -$0.44 | -25.7% |
| FY2021 | -$0.35 | +39.7% |
| FY2020 | -$0.58 | -241.2% |
| FY2019 | -$0.17 | -13.3% |
| FY2018 | -$0.15 | -162.5% |
| FY2017 | $0.24 | +123.3% |
| FY2016 | -$1.03 | -157.5% |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026